A CASE REPORT OF INTENSIVE CARE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS WITH ACUTE RESPIRATORY FAILURE: DIAGNOSIS, TREATMENT AND MANAGEMENT

Myasthenia gravis is an autoimmune disorder causing muscle weakness and fatiguability due to the antibody against acetylcholine receptor. The disease is characterised by frequent relapse and remission and respiratory distress resulting in myasthenic crisis. Management of disease revolves around suppression of symptoms and disease pathology. Treatment options include acetylcholinesterase inhibitors, steroids, immunosuppressants and plasma exchange therapies. We present a case of 24-year-oldfemale with a known case of myesthenia gravis who showed failure to conventional therapy with pyridostigmine, steroids and IVIG. She received 5 cycles of PLEX to overcome the myesthenic crisis followed by rituximab. She was kept on a maintainence dose of steroids and immunosuppressants. Her course in icu was stormy with respiratory distress requiring intubation and mechanical ventilation and development of VAP. She was extubated after 4 cycles of PLEX and VAP management.

Authors

Publication Details

Journal
International Journal of Advanced Research
Published
2025-05-31
DOI
https://doi.org/10.21474/ijar01/21025
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A CASE REPORT OF INTENSIVE CARE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS WITH ACUTE RESPIRATORY FAILURE: DIAGNOSIS, TREATMENT AND MANAGEMENT

Poonam Negi, G. A. Manjunath, Dhenesh Rajavel, Senthilnathan Senthilnathan
1 links
International Journal of Advanced Research
Myasthenia Gravis and Thymoma
article

A CASE REPORT OF INTENSIVE CARE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS WITH ACUTE RESPIRATORY FAILURE: DIAGNOSIS, TREATMENT AND MANAGEMENT

Poonam Negi, G. A. Manjunath, Dhenesh Rajavel, Senthilnathan Senthilnathan
article en

Abstract

Myasthenia gravis is an autoimmune disorder causing muscle weakness and fatiguability due to the antibody against acetylcholine receptor. The disease is characterised by frequent relapse and remission and respiratory distress resulting in myasthenic crisis. Management of disease revolves around suppression of symptoms and disease pathology. Treatment options include acetylcholinesterase inhibitors, steroids, immunosuppressants and plasma exchange therapies. We present a case of 24-year-oldfemale with a known case of myesthenia gravis who showed failure to conventional therapy with pyridostigmine, steroids and IVIG. She received 5 cycles of PLEX to overcome the myesthenic crisis followed by rituximab. She was kept on a maintainence dose of steroids and immunosuppressants. Her course in icu was stormy with respiratory distress requiring intubation and mechanical ventilation and development of VAP. She was extubated after 4 cycles of PLEX and VAP management.

International Journal of Advanced ResearchVol. 13(05)
Good health and well-being
Openalex Percentile: Top 78%
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A CASE REPORT OF INTENSIVE CARE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS WITH ACUTE RESPIRATORY FAILURE: DIAGNOSIS, TREATMENT AND MANAGEMENT — Poonam Negi, G. A. Manjunath, et al. · International Journal of Advanced Research (2025) | TGRS Research Map | TGRS